Author of the publication

Detection of genomic aberrations in molecularly defined Burkitt's lymphoma by array-based, high resolution, single nucleotide polymorphism analysis

, , , , , , , , , , , , , , , , , and . Haematologica, 95 (12): 2047–2055 (2010)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Detection of genomic aberrations in molecularly defined Burkitt's lymphoma by array-based, high resolution, single nucleotide polymorphism analysis, , , , , , , , , and 8 other author(s). Haematologica, 95 (12): 2047–2055 (2010)Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group, , , , , , , , , and . Blood, 116 (18): 3418–3425 (2010)NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity, , , , , , , , , and 11 other author(s). Circulation, 112 (24): 3754–3762 (2005)Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60), , , , , , , , , and 16 other author(s). The Lancet Oncology, 9 (2): 105–116 (2008)Dose-escalated CHOP plus etoposide (MegaCHOEP) followed by repeated stem cell transplantation for primary treatment of aggressive high-risk non-Hodgkin lymphoma, , , , , , , , , and . Blood, 107 (8): 3058–3064 (2006)Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: an exploratory study, , , , , , , , , and 3 other author(s). Clinical cancer research : an official journal of the American Association for Cancer Research, 14 (12): 3777–3784 (2008)A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling, , , , , , , , , and 25 other author(s). The New England journal of medicine, 354 (23): 2419–2430 (2006)MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma, , , , , , , , , and 10 other author(s). Blood, 121 (12): 2253–2263 (2013)Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma, , , , , , , , , and 6 other author(s). Blood, 119 (8): 1882–1887 (2012)Recurrent deletions of the TNFSF7 and TNFSF9 genes in 19p13.3 in diffuse large B-cell and Burkitt lymphomas, , , , , , , , , and 1 other author(s). International journal of cancer. Journal international du cancer, 131 (5): E830-5 (2012)